SCHEMBL12014690

SCHEMBL12014690

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc4c(-c5ccc6ccc7cccc8ccc5c6c78)c5cc(N(c6ccc(-c7ccccc7)cc6)c6ccc(-c7ccccc7)cc6)ccc5c(-c5ccc6ccc7cccc8ccc5c6c78)c4c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.37
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP3A4 P08684 2/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
THRB P10828 1/20 0.33
HSD17B1 P14061 2/20 0.31
HSD17B2 P37059 2/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14330789 0.99 CYP1A2 (0.36) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12014686 0.93 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14099808 0.91 HSD17B1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12014688 0.89 CYP1A2 (0.37) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL19953861 0.86 CYP1A2 (0.39) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18174838 0.86 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12014715 0.85 CRHBP (0.36) ALDH1A1HPGDHSD17B10TSHRL3MBTL1
SCHEMBL14099812 0.85 ESR1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12014673 0.85 MCL1 (0.40) ALDH1A1HPGDHSD17B10TSHRTDP1
SCHEMBL18174845 0.84 CYP1A2 (0.39) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed
WO-2011110276-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-09-15 WO disclosed
WO-2011054442-A2 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES EFNA1, DDT, ERCC1 CYP1A2 578/4885ERBB2 2053/4885FYN 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.